127 related articles for article (PubMed ID: 30531307)
1. Copy-Years Viremia and Risk of Virological Failure in Long-Term-Treated HIV Patients.
Falasca F; De Vito C; Mazzuti L; di Carlo D; Celani L; Fimiani C; dʼEttorre G; Mezzaroma I; Antonelli G; Turriziani O
J Acquir Immune Defic Syndr; 2019 Apr; 80(4):423-428. PubMed ID: 30531307
[TBL] [Abstract][Full Text] [Related]
2. Viremia copy-years as a predictive marker of all-cause mortality in HIV-1-infected patients initiating a protease inhibitor-containing antiretroviral treatment.
Chirouze C; Journot V; Le Moing V; Raffi F; Piroth L; Reigadas S; Cassuto JP; Chêne G; Leport C; Hoen B;
J Acquir Immune Defic Syndr; 2015 Feb; 68(2):204-8. PubMed ID: 25590273
[TBL] [Abstract][Full Text] [Related]
3. Low-level viraemia, measured as viraemia copy-years, as a prognostic factor for medium-long-term all-cause mortality: a MASTER cohort study.
Quiros-Roldan E; Raffetti E; Castelli F; Focà E; Castelnuovo F; Di Pietro M; Gagliardini R; Gori A; Saracino A; Fornabaio C; Sighinolfi L; Di Filippo E; Maggiolo F; Donato F
J Antimicrob Chemother; 2016 Dec; 71(12):3519-3527. PubMed ID: 27543658
[TBL] [Abstract][Full Text] [Related]
4. Cumulative HIV Viremia Copy-Years and Hypertension in People Living with HIV.
Xu Y; Chen X; Wijayabahu A; Zhou Z; Yu B; Spencer EC; Cook RL
Curr HIV Res; 2020; 18(3):143-153. PubMed ID: 32003696
[TBL] [Abstract][Full Text] [Related]
5. Determinants of viremia copy-years in people with HIV/AIDS after initiation of antiretroviral therapy.
Wright ST; Hoy J; Mulhall B; Oʼconnor CC; Petoumenos K; Read T; Smith D; Woolley I; Boyd MA
J Acquir Immune Defic Syndr; 2014 May; 66(1):55-64. PubMed ID: 24463783
[TBL] [Abstract][Full Text] [Related]
6. Viremia copy-years and mortality among combination antiretroviral therapy-initiating HIV-positive individuals: how much viral load history is enough?
Wang R; Haberlen SA; Palella FJ; Mugavero MJ; Margolick JB; Macatangay BJC; Martínez-Maza O; Jacobson LP; Abraham AG
AIDS; 2018 Nov; 32(17):2547-2556. PubMed ID: 30379686
[TBL] [Abstract][Full Text] [Related]
7. Viral load monitoring and antiretroviral treatment outcomes in a pediatric HIV cohort in Ghana.
Kukoyi O; Renner L; Powell J; Barry O; Prin M; Kusah J; Cong X; Paintsil E
BMC Infect Dis; 2016 Feb; 16():58. PubMed ID: 26843068
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 Very Low Level Viremia Is Associated with Virological Failure in Highly Active Antiretroviral Treatment-Treated Patients.
Calcagno A; Motta I; Ghisetti V; Lo Re S; Allice T; Marinaro L; Milia MG; Tettoni MC; Trentini L; Orofino G; Salassa B; Di Perri G; Bonora S
AIDS Res Hum Retroviruses; 2015 Oct; 31(10):999-1008. PubMed ID: 26165150
[TBL] [Abstract][Full Text] [Related]
9. Virological Outcome After Choice of Antiretroviral Regimen Guided by Proviral HIV-1 DNA Genotyping in a Real-Life Cohort of HIV-Infected Patients.
Meybeck A; Alidjinou EK; Huleux T; Boucher A; Tetart M; Choisy P; Bocket L; Ajana F; Robineau O
AIDS Patient Care STDS; 2020 Feb; 34(2):51-58. PubMed ID: 32049556
[TBL] [Abstract][Full Text] [Related]
10. Very low level viraemia and risk of virological failure in treated HIV-1-infected patients.
Teira R; Vidal F; Muñoz-Sánchez P; Geijo P; Viciana P; Ribera E; Domingo P; Castaño M; Martínez E; Roca B; Puig T; Estrada V; Deig E; Galindo MJ; de la Fuente B; Lozano F; Montero M; Muñoz-Sanz A; Sanchez T; Terrón A; Romero-Palacios A; Lacalle JR; Garrido M; Suárez-Lozano I;
HIV Med; 2017 Mar; 18(3):196-203. PubMed ID: 27476742
[TBL] [Abstract][Full Text] [Related]
11. Risk of virological failure in HIV-1-infected patients experiencing low-level viraemia under active antiretroviral therapy (ANRS C03 cohort study).
Vandenhende MA; Perrier A; Bonnet F; Lazaro E; Cazanave C; Reigadas S; Chêne G; Morlat P;
Antivir Ther; 2015; 20(6):655-60. PubMed ID: 25735799
[TBL] [Abstract][Full Text] [Related]
12. Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients.
; Vandenhende MA; Ingle S; May M; Chene G; Zangerle R; Van Sighem A; Gill MJ; Schwarze-Zander C; Hernandez-Novoa B; Obel N; Kirk O; Abgrall S; Guest J; Samji H; D'Arminio Monforte A; Llibre JM; Smith C; Cavassini M; Burkholder GA; Shepherd B; Crane HM; Sterne J; Morlat P
AIDS; 2015 Jan; 29(3):373-83. PubMed ID: 25686685
[TBL] [Abstract][Full Text] [Related]
13. Associations between HIV-1 DNA copy number, proviral transcriptional activity, and plasma viremia in individuals off or on suppressive antiretroviral therapy.
Hong F; Jacobs JL; Aga E; Cillo AR; Fyne E; Koontz DL; Zheng L; Mellors JW
Virology; 2018 Aug; 521():51-57. PubMed ID: 29879542
[TBL] [Abstract][Full Text] [Related]
14. Full Viral Suppression, Low-Level Viremia, and Quantifiable Plasma HIV-RNA at the End of Pregnancy in HIV-Infected Women on Antiretroviral Treatment.
Baroncelli S; Pirillo MF; Tamburrini E; Guaraldi G; Pinnetti C; Degli Antoni A; Galluzzo CM; Stentarelli C; Amici R; Floridia M
AIDS Res Hum Retroviruses; 2015 Jul; 31(7):673-8. PubMed ID: 25769019
[TBL] [Abstract][Full Text] [Related]
15. How relevant is the HIV low level viremia and how is its management changing in the era of modern ART? A large cohort analysis.
Taramasso L; Magnasco L; Bruzzone B; Caligiuri P; Bozzi G; Mora S; Balletto E; Tatarelli P; Giacomini M; Di Biagio A
J Clin Virol; 2020 Feb; 123():104255. PubMed ID: 31927152
[TBL] [Abstract][Full Text] [Related]
16. Ultrasensitive assessment of residual low-level HIV viremia in HAART-treated patients and risk of virological failure.
Maggiolo F; Callegaro A; Cologni G; Bernardini C; Velenti D; Gregis G; Quinzan G; Soavi L; Iannotti N; Malfatto E; Leone S
J Acquir Immune Defic Syndr; 2012 Aug; 60(5):473-82. PubMed ID: 22481602
[TBL] [Abstract][Full Text] [Related]
17. Any impact of blips and low-level viraemia episodes among HIV-infected patients with sustained virological suppression on ART?
Pernas B; Grandal M; Pertega S; Cañizares A; Castro-Iglesias Á; Mena Á; Rodriguez-Osorio I; Tabernilla A; Pedreira JD; Poveda E
J Antimicrob Chemother; 2016 Apr; 71(4):1051-5. PubMed ID: 26702924
[TBL] [Abstract][Full Text] [Related]
18. HIV Viremia During Pregnancy and Neurodevelopment of HIV-Exposed Uninfected Children in the Context of Universal Antiretroviral Therapy and Breastfeeding: A Prospective Study.
le Roux SM; Donald KA; Kroon M; Phillips TK; Lesosky M; Esterhuyse L; Zerbe A; Brittain K; Abrams EJ; Myer L
Pediatr Infect Dis J; 2019 Jan; 38(1):70-75. PubMed ID: 30234792
[TBL] [Abstract][Full Text] [Related]
19. Viremia copy-years predicts mortality among treatment-naive HIV-infected patients initiating antiretroviral therapy.
Mugavero MJ; Napravnik S; Cole SR; Eron JJ; Lau B; Crane HM; Kitahata MM; Willig JH; Moore RD; Deeks SG; Saag MS;
Clin Infect Dis; 2011 Nov; 53(9):927-35. PubMed ID: 21890751
[TBL] [Abstract][Full Text] [Related]
20. Viremia copy-years and risk of estimated glomerular filtration rate reduction in adults living with perinatal HIV infection.
Sarteschi G; Di Biagio A; Focà E; Taramasso L; Bovis F; Celotti A; Mirabella M; Magnasco L; Mora S; Giacomini M; Bassetti M
PLoS One; 2020; 15(10):e0240550. PubMed ID: 33057418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
